Announcements
Expression of concern regarding paper by Park et al, published on 25 June 2015: “Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015”, Euro Surveill. 2015;20(25):pii=21169. It has been brought to our attention that some of the authors may not have been informed about the content of the above paper. There is a lack of clarity regarding rights to use the data. The editorial team are investigating what action needs to be taken.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance


In this issue


Home Eurosurveillance Edition  2015: Volume 20/ Issue 47 Article 5
Back to Table of Contents
Previous Download (pdf)
Next

Eurosurveillance, Volume 20, Issue 47, 26 November 2015
News
Eurosurveillance editorial team: New European HIV Test Finder launched during European HIV-Hepatitis Testing Week

+ Author affiliations


Citation style for this article: Eurosurveillance editorial team. New European HIV Test Finder launched during European HIV-Hepatitis Testing Week. Euro Surveill. 2015;20(47):pii=30072. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2015.20.47.30072


On the occasion of the 20–27 November European HIV-Hepatitis Testing Week, the European HIV Test Finder, an online tool supporting people to find HIV-testing sites across Europe has been launched [1].

The European HIV Test Finder lists HIV testing centres and clinics across the 28 European Union (EU) member states. It was developed by Aidsmap.com with funding from the European Centre for Disease Prevention and Control (ECDC). Mobile friendly, it enables people to search for a nearby HIV testing centre by country, town and area code [2].

During the European HIV-Hepatitis Testing Week [3], the European Test Finder has been actively promoted via smartphone dating apps for men who have sex with men (MSM), thereby further disseminating the message that it is important to be tested. A newly published report [4] shows that sex between men is still the most common way HIV is transmitted in the EU/ European Economic Area. HIV diagnoses among MSM have been rising at a significant rate from 30% of cases diagnosed in 2005 to 42% in 2014.

The European HIV Testing Week was first organised in 2013. Its aim is to increase HIV status awareness and to communicate the benefits of HIV testing with an aim to reduce late diagnosis. Current data shows that 47% of newly reported HIV cases are diagnosed late. Those tested and diagnosed with HIV early are less likely to pass on the virus [4].



References

  1. European Centre for Disease Prevention and Control (ECDC). Stockholm: ECDC; 2015. Available from: http://ecdc.europa.eu/en/press/news/_layouts/forms/News_DispForm.aspx?ID=1325&List=8db7286c-fe2d-476c-9133-18ff4cb1b568&Source=http%3A%2F%2Fecdc.europa.eu%2Fen%2FPages%2Fhome.aspx

  2. Aidsmap NAM. [Accessed 26 Nov 2015]. Available from: http://www.aidsmap.com/european-hiv-test-finder

  3. European HIV-Hepatitis Testing Week. [Accessed 26 Nov 2015]. Available from: http://www.testingweek.eu/

  4. European Centre for Disease Prevention and Control, World Health Organization Regional Office for Europe. (ECDC, WHO). HIV/AIDS surveillance in Europe 2014. Stockholm: ECDC; 2015. [Accessed 26 Nov 2015]. Available from: http://ecdc.europa.eu/en/publications/Publications/hiv-aids-surveillance-in-Europe-2014.pdf



Back to Table of Contents
Previous Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.